Back to companies

Amneal Pharmaceuticals Inc: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Amneal Pharmaceuticals Inc (Amneal), formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company. It produces generic, specialty pharmaceutical products. Its product portfolio includes generic and specialty drugs in the therapeutic areas of oncology, inflammation and pain, central nervous system disorders, endocrinology and parasitic infections. The company offers products in various dosage forms such as oral solids and liquids, injectables, topicals, creams and ointments, transdermals, inhalation, ophthalmic and otic liquids and other device driven products. Amneal also offers services which include product research and development, active pharmaceutical ingredient (API) manufacturing, packaging, distribution and account management. The company has operational facilities across the US, India and Ireland as well as commercial offices in Switzerland, Germany, the UK, Australia, Spain, Germany, Switzerland and Scandinavia. Amneal is headquartered in Bridgewater, New Jersey, the US.

Headquarters United States of America

Address 400 Crossing Blvd Fl 3, Bridgewater, New Jersey, 08807-2863


Telephone 1 908 9473120

No of Employees 7,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange AMRX (NYSE)

Revenue (2021) $2.1B 5.1% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -88.3% (2021 vs 2020)

Market Cap* $1.1B

Net Profit Margin (2021) XXX -88.8% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

430+

Marketed Drugs

Understand Amneal Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

100+

Clinical Trials

Determine Amneal Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Amneal Pharmaceuticals Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Amneal Pharmaceuticals Inc’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Amneal Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

14+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

13+

Pipeline Drugs

Identify which of Amneal Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

5

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

4

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services
Specialty Products Research and Services
Generics Products
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In January, the company entered into an agreement to acquire Baclofen Franchise from Saol Therapeutics.
2021 Acquisitions/Mergers/Takeovers In November, the company acquired Puniska Healthcare for US$93 million.
2021 Contracts/Agreements In May, the company and Acerus Pharmaceuticals entered into a co-promotion agreement for NATESTO.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Amneal Pharmaceuticals Inc AbbVie Inc Gilead Sciences Inc ANI Pharmaceuticals Inc Revolution Medicines Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Bridgewater North Chicago Foster City Baudette Redwood City
State/Province New Jersey Illinois California Minnesota California
No. of Employees 7,000 50,000 14,400 601 201
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Paul Meister Chairman Executive Board 2019 68
Chirag Patel Co-Founder; Director; President; Co-Chief Executive Officer; Co-chairman Executive Board 2019 54
Chintu Patel Director; Co-Chief Executive Officer Executive Board 2019 49
Tasos Konidaris Senior Vice President; Chief Financial Officer Senior Management 2020 53
David A. Buchen Corporate Secretary; Senior Vice President; Chief Legal Officer Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer